Method for preventing adverse pregnancy outcomes due to use of selective serotonin reuptake inhibitors (ssri) during gestation
AssigneeWisconsin Alumni Research Foundation
InventorsLaura Hernandez, Rafael Reis Domingues, Milo Wiltbank
Life of this patent
Estimating the term…
Abstract
A method to inhibit adverse pregnancy outcomes in a pregnant mammal via administering to the pregnant mammal who is concurrently taking a selective serotonin reuptake inhibitor (SSRI) a therapeutically effective amount of a serotonin receptor antagonist.
Claims11
A method to inhibit adverse pregnancy outcomes in a pregnant mammal comprising administering to the pregnant mammal a therapeutically effective amount of a serotonin receptor antagonist.
A method to inhibit adverse pregnancy outcomes in a pregnant mammal comprising administering to a pregnant mammal who is concurrently taking a selective serotonin reuptake inhibitor (SSRI) a therapeutically effective amount of a serotonin receptor antagonist.
Dependencies are inferred from the claim text.